Ignite Creation Date:
2024-07-17 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06477523
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2024-06-19
Brief Title:
Phase 1b2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC
Sponsor:
Sichuan University
Organization:
Sichuan University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| SCLC Extensive Stage |
Keywords: